FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a bone implant matrix. Said matrix comprises a base matrix, the surface of which is coated with a statistically homogeneous composition, which is a reinforcing mixture containing a soluble polymer, substance capable of stimulating cell rooting and cell growth by stimulating cell proliferation and integration into tissues, selected from a group consisting of gelatine, hydrolysed gelatine, and at least one artificial proline-rich peptide with an amino acid sequence selected from SEQ ID NO: 3 – SEQ ID NO: 9.
EFFECT: present invention provides a bone implant matrix for surgical repair of bone tissue in general and use in implantology.
15 cl, 12 dwg, 6 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CONTROLLED RELEASE THERAPEUTIC AGENTS CONTAINING PEPTIDES | 2009 |
|
RU2543327C2 |
| BONE IMPLANT MATRIX AND METHOD FOR PREPARING IT | 2009 |
|
RU2532385C2 |
| BIOCOMPATIBLE BIODEGRADABLE OSTEOCONDUCTIVE POLYMER COMPOSITE MATERIAL FOR BONE TISSUE REGENERATION | 2018 |
|
RU2708396C1 |
| PROCOAGULANT PEPTIDES, THEIR DERIVATIVES AND THEIR APPLICATION | 2012 |
|
RU2635510C2 |
| PEPTIDE COMPOUNDS AND THEIR THERAPEUTIC USE | 2019 |
|
RU2812775C2 |
| PEPTIDE CONJUGATED PARTICLES | 2014 |
|
RU2685186C2 |
| PLATFORM BASED ON CYSTEINE KNOT SCAFFOLD | 2016 |
|
RU2770384C2 |
| COMPOSITIONS AND METHODS FOR PREVENTING RADIATION DAMAGE AND STIMULATING TISSUE REGENERATION | 2018 |
|
RU2772456C2 |
| HAEMOSTATIC WOUND DRESSING | 2013 |
|
RU2661036C2 |
| USE OF SUBSTANCES FOR TREATING VISION LOSS IN INDIVIDUALS SUFFERING GLAUCOMA AND OTHER DEGENERATIVE OCULAR DISEASES | 2008 |
|
RU2481120C2 |
